The aim of this study was to evaluate the correlation of preoperative serum CA 125 levels
and lymph node metastasis in patients with endometrial cancer. Preoperative levels of …

Serum levels of CA 125 and CA 15-3 were measured in 148 patients with primary
endometrial carcinoma. CA 125-positive levels were found in 33 and 22% of the cases using …

The serum levels of CA 125 and CA 19-9 were determined by an immunoradiometric assay
employing the monoclonal antibody OC 125 and anti-CA 19-9 antibody in 88 patients with …

Serum levels of CA125 and CA19-9 were examined in 225 cases with endometrial
carcinoma before treatment and 32 cases with recurrent endometrial carcinoma. The …

Plasma levels of CA 125 were determined in 113 patients with ovarian cancer of epithelial
origin. Of these, 69 patients had CA 125 measured before the first laparotomy and 84.6% of …

Serial assay of serum CA 125 was carried out in five patients with advanced primary
carcinoma of the fallopian tube. Pretreatmental levels of these patients were elevated …

Our objective was to evaluate the diagnostic value of squamous cell carcinoma antigen
(SCC-ag) and cancer antigen (CA) 125 serum tumor markers for the detection of cervical …

Serum CA 125 levels were evaluated in 227 patients with ovarian cancer. CA 125 levels
were elevated in 86% of the patients. All histologic types, including mucinous tumors, were …

Most studies evaluating the role of serum CA 125 measurements in endometrial cancer
report a positive correlation with prognostic factors. The present study investigates the role of …

Elevated CA 125 level was noted in 0.2-5.9% healthy women, 22-27.8% patients with
benign ovarian cysts, and approximately 80% patients with nonmucinous ovarian cancer. In …